Nootropics Depot Reveals Surprising Turkesterone Test Results In Podcast With Greg Doucette


(MENAFN- PR Newswire)

Industry Leaders Reveal Shocking Test Results in Groundbreaking Podcast

TEMPE, Ariz., Jan. 7, 2025 /PRNewswire/ --
Nootropics Depot Reveals Surprising Turkesterone Test Results in Podcast with Greg Doucette.
Nootropics Depot, a leading manufacturer of high-quality dietary supplements, has released a podcast featuring IFBB pro bodybuilder Greg Doucette, founder of HTLT Supplements. The podcast, titled "The Turkesterone Scandal Just Got Deeper ," delves into the controversial 2022 turkesterone scandal that rocked the bodybuilding supplement industry, and reveals new lab test results showing the state of the turkesterone products on the market today.


Nootropics Depot Reveals Surprising Turkesterone Test Results In Podcast With Greg Doucette Image

High-Performance Thin-Layer Chromatography (HPTLC) analysis reveals stark differences between commercially available turkesterone products. Left lanes show authentic Ajuga turkestanica reference materials and verified products (TurkMax and TurkBuilder), while right lanes demonstrate competing products seeming to contain Cyanotica arachnoidea instead of genuine Ajuga turkestanica. The distinctive marker bands highlight the presence of true turkesterone versus its absence in competitor samples.
Ultra-Performance Liquid Chromatography (UPLC) analysis reveals the content differences between three products: Nootropics Depot's β-ecdysterone (blue line) shows high purity with a distinct peak. HTLT's Turk Builder (black line) contains both turkesterone and β-ecdysterone. A competitor's product (red line) shows minimal peaks, indicating significantly lower concentrations than claimed.

MENAFN07012025003732001241ID1109065673


PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.